期刊
BRITISH JOURNAL OF CANCER
卷 97, 期 3, 页码 302-307出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603876
关键词
HRQOL scores; prognostic factors; glioblastoma
类别
资金
- NCI NIH HHS [5U10CA11488-34, 5U10CA11488-30, U10 CA011488] Funding Source: Medline
This is one of the few studies that have explored the value of baseline symptoms and health- related quality of life ( HRQOL) in predicting survival in brain cancer patients. Baseline HRQOL scores ( from the EORTC QLQ- C30 and the Brain Cancer Module ( BN 20)) were examined in 490 newly diagnosed glioblastoma cancer patients for the relationship with overall survival by using Cox proportional hazards regression models. Refined techniques as the bootstrap re-sampling procedure and the computation of C- indexes and R-2- coefficients were used to try and validate the model. Classical analysis controlled for major clinical prognostic factors selected cognitive functioning ( P= 0.0001), global health status ( P= 0.0055) and social functioning ( P < 0.0001) as statistically significant prognostic factors of survival. However, several issues question the validity of these findings. C- indexes and R-2- coefficients, which are measures of the predictive ability of the models, did not exhibit major improvements when adding selected or all HRQOL scores to clinical factors. While classical techniques lead to positive results, more refined analyses suggest that baseline HRQOL scores add relatively little to clinical factors to predict survival. These results may have implications for future use of HRQOL as a prognostic factor in cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据